companyprofile

Actions

Al-Razi Medical Co.

9572
ALRAZI
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close -
  • Open N/A
  • High
  • Low
  • No. of Trades
  • Avg. Trade size* N/A
  • Volume Traded
  • Value Traded (SAR)

Performance

ALRAZI
- ( - )
Compare
Name Price Change %
Al-Razi Medical Co. %
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
-
% Change
-
Volume Traded
0

Best Bid

Price -
Volume -

Best Offer

Price -
Volume -

52 WEEK

High
88.90
2023/07/10
Low
47.10
2024/05/30
Change**
0.0

PERFORMANCE

Start of Year
Year ago
3 Years ago

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Al-Razi Medical Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting the ( First Meeting )

    9572
    ALRAZI 0.0 %
    1445/11/20     28/05/2024 08:01:54
  • Al-Razi Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

    9572
    ALRAZI 0.0 %
    1445/09/20     30/03/2024 16:24:15
  • Al Razi Medical Company announces the resignation of the company’s CEO and the appointment of a new CEO for the company

    9572
    ALRAZI 0.0 %
    1445/07/26     07/02/2024 08:09:03
  • Al-Razi Medical Co. announces its Interim Financial Results for the Period Ending on 2023-06-30 ( Six Months )

    9572
    ALRAZI 0.0 %
    1445/02/15     31/08/2023 16:08:54
  • Al-Razi Medical Co. announces the distribution of cash dividend for The first half of the year 2023

    9572
    ALRAZI 0.0 %
    1445/02/15     31/08/2023 15:43:24
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      31/08/2023 04/09/2023 13/09/2023 Account Transfer 0.39

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet
      Total Assets - - - -
      Total Liabilities - - - -
      Total Shareholders Equity (After Deducting the Minority Equity) - - - -
      Total Liabilities and Shareholders Equity - - - -
      Statement of Income
      Total Revenue (Sales/Operating) - - - -
      Net Profit (Loss) before Zakat and Tax - - - -
      Zakat and Income Tax - - - -
      Net Profit (Loss) after Zakat and Tax - - - -
      Total Comprehensive Income - - - -
      Profit (Loss) per Share - - - -
      Cash Flow
      Net Cash From Operating Activities - - - -
      Net Cash From Investing Activities - - - -
      Net Cash From Financing Activities - - - -
      Cash and Cash Equivalents, Beginning of the Period - - - -
      Cash and Cash Equivalents, End of the Period - - - -
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet
      Total Assets
      Total Liabilities
      Total Shareholders Equity (After Deducting the Minority Equity)
      Total Liabilities and Shareholders Equity
      Statement of Income
      Total Revenue (Sales/Operating)
      Net Profit (Loss) before Zakat and Tax
      Zakat and Income Tax
      Net Profit (Loss) after Zakat and Tax
      Total Comprehensive Income
      Profit (Loss) per Share
      Cash Flow
      Net Cash From Operating Activities
      Net Cash From Investing Activities
      Net Cash From Financing Activities
      Cash and Cash Equivalents, Beginning of the Period
      Cash and Cash Equivalents, End of the Period
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-13 يوسف عبدالله يوسف العريني Chairman 65.4552632% 65.4552632% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Al-Razi Medical Co.
      Price -
      Market Cap (SAR MN)
      P/E Ratio -
      Index Name Index Level 1D Return
      Al-Razi Medical Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The company operates under commercial registration number 1129000811 dated 2006/8/10 corresponding to 1427/7/15 AH The company s commercial activities as stated in its commercial registration consist of operating pharmacies under a license from the Ministry of Health with a license number of 6311403006110004 which expires on 1447/12/02 AH, and operating drug warehouses under a license from the Saudi Food and Drug Authority with a license number of 060401065 which expires on 1447/07/01 AH The company s activities as stated in its bylaws include the following purposes Buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis Human health, health centers, and social work activities Transportation and storage Real estate activities Construction Information and communication Scientific and technical activities Administrative services and support services Other services activities The company carries out its activities according to the applicable regulations and after obtaining the necessary licenses from the competent authorities if any The company s current activity consists of storing, selling and marketing pharmaceuticals medical supplies cosmetic and pharmaceutical products

      Company History

      Alrazi Medical Company was initially established as an individual institution under the name of Alrazi Medical Pharmacy, owned by Yousef Abdullah Youssef Alorini, under Commercial Registration No. 1129000811 issued by the City of Albadaya on 10 Aug 2006, with a capital of 15000 S.R. The legal entity of Alrazi Medical Pharmacy, owned by Yousef Abdullah Yousef Alorini, was transformed into a limited liability company pursuant to the amended Articles of Association and Commercial Registry No. 1129000811 issued by the City of Albadaya on 10 Aug 2006, with a capital of 250000 S.R, divided into 10,000 cash shares of equal value. The value of each of them is 25 Saudi riyals owned by Mr. Yousef Abdullah Yousef Alorini, with a number of shares 9800 shares, and Mrs. Fawzia Sulaiman Abdullah Alsaghir, with a number of shares 200 shares. The company name was changed to become Alrazi Medical Company on 30 Jun 2021 The partners decided to amend the nominal value of the shares from 25 Saudi riyals per share to 1200 one thousand two hundred Saudi riyals per share, and to increase the company capital from 250000 Saudi riyals to 12000000 Saudi riyals divided into 10000 equal shares, fully paid, with a value of 1200 Saudi riyals per share. On 08 Feb 2021, the partners agreed to adjust the value of the company shares from 1200. per share to 10 Saudi riyals per share, and the number of shares ranges from 10000 shares to 1200000 shares of equal value, as was agreed on 08 Feb 2021, with the entry of six partners. It was renewed through Mr. Yousef Abdullah Yousef Alorini assignment of a number of his shares to them, and on 08 Aug 2021, the partners decided to transform the legal entity of the company and its branches into a closed joint stock company with its rights, obligations, employment, classifications, licenses and all Its financial, technical and administrative components, and the capital increase from 12000000 Saudi riyals divided into 1200000 shares to 15200000 riyals divided into 1520000 shares, and the value of each share is 10 Saudi riyals by issuing 320000 new shares at a value of 10 ten riyals per share, which represents 20 of the company capital, plus an issue premium of 21.72 riyals per share. It was agreed to allocate the issue premium amount of 6950400 riyals as a balance for the company to expand the activity, and it was paid by the new partners in cash, bringing the number of current partners in the company to 73 shareholders. The company was registered in the register of joint stock companies in accordance with Ministerial Resolution No. 532 issued on 20 Sep 2021, and registered under Commercial Registry No. 1129000811 issued by the City of Albadaya on 10 Aug 2006.

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 15,200,000
      • Issued Shares 1,520,000
      • Paid Capital (SAR) 1,520,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2023-06-22

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2006/08/10

      • Financial Year End

        31/12

      • Listing Date

        2023/06/22

      • External Auditors

        [Ibrahim Ahmed Al-Bassam and Partners Company]

      • ISIN CODE

        SA15R0E4LI18

      • Number of Employees

        125

      • Chairman

        Yousef Abdullah Al-Areeni.
        Non - Executive

        Yousef Abdullah Al-Areeni.
        • BD Session Start
          2021-09-20
          Designation
          Chairman
        • BD Session End
          2026-09-19
          Classification
          Non - Executive
      • Board of Directors

        Abdullah Nasser Ibrahim Al-Daajan Deputy Chairman - Non Executive

        Abdullah Nasser Ibrahim Al-Daajan
        • BD Session Start
          2021-09-20
          Designation
          Board of Directors
        • BD Session End
          2026-09-19
          Classification
          Deputy Chairman - Non Executive

        Abdulrahman Mohammed Abdullah Al-Shehbany Non - Executive

        Abdulrahman Mohammed Abdullah Al-Shehbany
        • BD Session Start
          2021-09-20
          Designation
          Board of Directors
        • BD Session End
          2026-09-19
          Classification
          Non - Executive

        Muhammad Abdullah Muhammad Al-Mousa Non - Executive

        Muhammad Abdullah Muhammad Al-Mousa
        • BD Session Start
          2021-09-20
          Designation
          Board of Directors
        • BD Session End
          2026-09-19
          Classification
          Non - Executive

        Abdulaziz Abdullah Mohammed Al-Aoud Non - Executive

        Abdulaziz Abdullah Mohammed Al-Aoud
        • BD Session Start
          2021-09-20
          Designation
          Board of Directors
        • BD Session End
          2026-09-19
          Classification
          Non - Executive
      • Senior Executives

        Mohamed Hassan Dawoud CEO

        Mohamed Hassan Dawoud
        • BD Session Start
          2024-02-06
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        AHMED ABDELKHALEK IBRAHIM CFO

      AHMED ABDELKHALEK IBRAHIM
      • BD Session Start
        2024-04-25
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Mohammed Abdulrahman Mohammed Al-Suhaybani

      Company Address:

      King Abdulaziz Road - Al-Khaleej District - Al-Bada'ea - Al-Qassim - Kingdom of Saudi Arabia.

      Contact Details:

      Telephone: 0163329999
      Fax : 0163317777
      Email : info@alraziksa.com

      Company Website:

      www.razi.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.